drugset / Trial / NCT04349592

Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19

NCT04349592

Completed 456 enrolled Hamad Medical Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Q-PROTECT is a placebo controlled randomized trial (RCT) to ascertain the efficacy of hydroxychloroquine (HC) alone or, in combination with azithromycin (AZ), in reducing viral load in patients with COVID 19.

Timeline

Start
2020-04-14
Primary completion
2020-08-14
Completion
2020-08-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 250 mg Oral
Subject Hydroxychloroquine Small molecule 200 mg Oral

Indications